• USEF Network Reminder, if you missed last weekend's @platinumperf /USEF Talent Search Finals East, all the phases are on demand: 10/8/2015 4:27:26 PM
  • USEF Network .@Noelle_Floyd You are correct, our bad! 10/8/2015 1:43:18 PM
  • USEF Network We will have the @nsbits /USEF Junior Jumping Championship and Pessoa/USEF Medal Final available to watch on-demand early next week 10/7/2015 5:04:58 PM
  • USEF Network @cnnsport chatted with Laura Sumrall about her winning freestyle reining performance to Frozen's 'Let it Go': 10/6/2015 4:10:05 PM
  • USEF Network .@PicChick1 The top 10 results were just live streamed. Top 4 in order: Tori, McKayla, Hunter, TJ. Will post complete results ASAP 10/4/2015 2:42:38 PM
  • USEF Network .@PicChick1 We streamed all the way through the awards. If you missed it we will have it all available on demand early next week. 10/4/2015 2:41:16 PM
  • USEF Network We have posted the 4 rides from the final round of the ride-off on our Facebook page for anyone that missed it: 10/4/2015 2:36:30 PM
  • USEF Network Leading Trainer: Andre Dignelli 10/4/2015 2:32:42 PM
  • USEF Network Grapa Trophy (Best Horse) winner: Skyfall owned by Linda Langmeier 10/4/2015 2:31:23 PM
  • USEF Network Talent Search Finals East 2015 Champion: Tori Colvin riding Avalanche 10/4/2015 2:24:43 PM


USEF Approves Use of New NSAID Firocoxib Beginning August 1, 2007

RELEASE: July 2, 2007

(Lexington, KY) - The Board of Directors of the United States Equestrian Federation has approved the use of the new non-steroidal anti-inflammatory drug (NSAID) EQUIOXX® (firocoxib). This new NSAID is the first highly COX-1 sparing drug to be FDA approved for use in horses.

The rule allowing the use of firocoxib will take effect on 8/1/07. Until this time, the use of firocoxib is restricted to use outside competition.

The new rule lists firocoxib as a NSAID with a restrictive quantitative limit, and allows for a maximum permitted concentration of 0.240 micrograms per milliliter of blood plasma. The recommendation for appropriate dose and time consideration is to follow the manufacturer’s guidelines for its use at 0.1 milligram per kilogram of body weight once daily. This corresponds with a 45.5 milligram dose for a 1000 lb. horse, and should be given no sooner than 12 hours prior to competing. Firocoxib is permitted to be used for a period of 14 consecutive days.

Until further review by the FEI, per manufacturer recommendation firocoxib should not be used in a horse in the 30 days prior to competing in an FEI sanctioned event.

For more information contact Maria Partlow, Senior Vice President of Marketing and Communications, or (859) 225-6941